Team:Freiburg/Notebook/modeling

From 2013.igem.org

(Difference between revisions)
Line 65: Line 65:
<div>
<div>
-
<table id="Fig4" class="gelpic">
+
<table class="imgtxt" width="500px">
-
<tbody><tr>  
+
<tr>  
-
<td> <img style="width:600px" src="https://static.igem.org/mediawiki/2013/8/88/Transfektionschema20.8.png"> </td><tr>
+
<td> <img class="imgtxt" width="500px" src="https://static.igem.org/mediawiki/2013/8/88/Transfektionschema20.8.png"> </td>
-
+
-
<td> <b> Fig. 1: Transfection Scheme </b></td>
+
</tr>
</tr>
-
</tbody></table>
+
<tr>
-
</div>   
+
<td> <b>Figure 1: <b> Transfection Scheme</b> </b><br>
 +
Cells were transfected with dCas9-VP16 (transfection one) or dCas9-KRAB (transfection 3). As controll we used .... (trandfection 3 and 4).
 +
</td>
 +
</tr>
 +
</table>
 +
</div>
 +
 
 +
   
<p>
<p>
Line 87: Line 92:
<p>
<p>
-
Every timepoint the supernant was taken for SEAP measurement and the cells were lysated with RIPA buffer for quantitative western blotting.<br>
+
Every timepoint the supernant was taken for SEAP measurement and the cells were lysated with RIPA buffer for quantitative western blotting.<br><br>
-
The standard western blot procedure was done with 20 µl of the cell lysates.<br>
+
The standard western blot procedure was done with 20 µl of the cell lysates.<br><br>
-
For quantification of the western blot data, a dot blot was done. <br>
+
For quantification of the western blot data, a dot blot was done. A serial dilution of anti-HA (200ng/µl)was prepared. After PVDF-membran activation and a short incubation in tranfer buffer, 2 µl of each dilution have been droped onto the membrane. After that the membrane was indubated at room temerature (1h) for drying.<br>
 +
The detection with the secondary anti-body was done similar to the treatment of the dCas9 blots.<br><br>
</p>
</p>

Revision as of 07:48, 4 October 2013


Modeling Notebook

65000 cells per well were seeded. 24 h before transfection.
The cells had been transfected at 21:30 h.

Figure 1: Transfection Scheme
Cells were transfected with dCas9-VP16 (transfection one) or dCas9-KRAB (transfection 3). As controll we used .... (trandfection 3 and 4).

To generate time dependent data, one well was treated every 6 h.

t0= 01:30
t1= 07:30
t2= 13:30
t3= 19:30
t4= 01:30
t5= 07:50
t6= 13:30

Every timepoint the supernant was taken for SEAP measurement and the cells were lysated with RIPA buffer for quantitative western blotting.

The standard western blot procedure was done with 20 µl of the cell lysates.

For quantification of the western blot data, a dot blot was done. A serial dilution of anti-HA (200ng/µl)was prepared. After PVDF-membran activation and a short incubation in tranfer buffer, 2 µl of each dilution have been droped onto the membrane. After that the membrane was indubated at room temerature (1h) for drying.
The detection with the secondary anti-body was done similar to the treatment of the dCas9 blots.